Free Trial

Applied Therapeutics (APLT) News Today

Applied Therapeutics logo
$9.90 -0.34 (-3.32%)
(As of 11/12/2024 ET)
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Hits New 12-Month High - Time to Buy?
Applied Therapeutics (NASDAQ:APLT) Sets New 12-Month High - Time to Buy?
Applied Therapeutics Advances with Govorestat Approvals
Applied Therapeutics (APLT) Gets a Buy from RBC Capital
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Rating of "Buy" from Analysts
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six brokerages that are presently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a
Applied Therapeutics (APLT) Gets a Buy from William Blair
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Sets New 12-Month High - Here's Why
Applied Therapeutics (NASDAQ:APLT) Reaches New 1-Year High - Should You Buy?
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 14,530,000 shares, a growth of 17.6% from the September 30th total of 12,360,000 shares. Based on an average trading volume of 2,510,000 shares, the days-to-cover ratio is currently 5.8 days.
Applied Therapeutics, Inc. stock logo
Hennion & Walsh Asset Management Inc. Raises Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT)
Hennion & Walsh Asset Management Inc. lifted its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 34.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 265,372 shares of the company's stock after purch
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Shares Down 4.9% - What's Next?
Applied Therapeutics (NASDAQ:APLT) Stock Price Down 4.9% - Here's What Happened
Applied Therapeutics call volume above normal and directionally bullish
Applied Therapeutics put volume heavy and directionally bearish
Applied Therapeutics, Inc. stock logo
William Blair Issues Pessimistic Estimate for APLT Earnings
Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) - William Blair decreased their Q2 2025 earnings per share (EPS) estimates for Applied Therapeutics in a report released on Tuesday, October 22nd. William Blair analyst L. Hanbury-Brown now forecasts that the company will earn ($0.11) per sha
William Blair Reaffirms Their Buy Rating on Applied Therapeutics (APLT)
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Trading Down 2.2% - Here's What Happened
Applied Therapeutics (NASDAQ:APLT) Stock Price Down 2.2% - Time to Sell?
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Shares Up 6.4% - Should You Buy?
Applied Therapeutics (NASDAQ:APLT) Trading Up 6.4% - Time to Buy?
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Sees Significant Growth in Short Interest
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 12,360,000 shares, a growth of 14.2% from the September 15th total of 10,820,000 shares. Based on an average trading volume of 2,390,000 shares, the short-interest ratio is currently 5.2 days.
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Average Rating of "Buy" from Brokerages
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) has earned a consensus recommendation of "Buy" from the six ratings firms that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has given a strong buy reco
Applied Therapeutics, Inc. stock logo
Sei Investments Co. Invests $535,000 in Applied Therapeutics, Inc. (NASDAQ:APLT)
Sei Investments Co. purchased a new stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 114,619 shares of the company's stock, valued at approx
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Trading 6.6% Higher - What's Next?
Applied Therapeutics (NASDAQ:APLT) Shares Up 6.6% - Time to Buy?
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Shares Down 5.7%
Applied Therapeutics (NASDAQ:APLT) Shares Down 5.7%
Applied Therapeutics, Inc. stock logo
Logos Global Management LP Lowers Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT)
Logos Global Management LP reduced its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 55.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of the co
Applied Therapeutics, Inc. stock logo
Perceptive Advisors LLC Has $37.38 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)
Perceptive Advisors LLC cut its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 5.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 8,005,000 shares of the company's stock after selling 500,000 shares during the quarter. Perceptive Adv
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Sees Large Growth in Short Interest
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 10,820,000 shares, an increase of 10.7% from the August 31st total of 9,770,000 shares. Based on an average daily trading volume, of 2,380,000 shares, the days-to-cover ratio is presently 4.5 days.
Applied Therapeutics, Inc. stock logo
Frazier Life Sciences Management L.P. Increases Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT)
Frazier Life Sciences Management L.P. boosted its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 17.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,286,135 shares of the company'
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Stock Price Up 5.2%
Applied Therapeutics (NASDAQ:APLT) Shares Up 5.2%
Applied Therapeutics, Inc. stock logo
Rhumbline Advisers Buys 133,351 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)
Rhumbline Advisers grew its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 24,513.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 133,895 shares of the company'
Applied Therapeutics, Inc. stock logo
Logos Global Management LP Sells 750,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)
Logos Global Management LP decreased its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 55.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of t
Applied Therapeutics, Inc. stock logo
Q2 2025 Earnings Forecast for Applied Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:APLT)
Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) - Research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for Applied Therapeutics in a research note issued to investors on Wednesday, September 18th. Leerink Partnrs analyst J. Schwartz now expects that the c
Applied Therapeutics, Inc. stock logo
Bank of New York Mellon Corp Takes $1.33 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)
Bank of New York Mellon Corp bought a new position in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 283,793 shares of the company's stock,
Applied Therapeutics, Inc. stock logo
Citigroup Boosts Applied Therapeutics (NASDAQ:APLT) Price Target to $11.00
Citigroup increased their price objective on shares of Applied Therapeutics from $8.00 to $11.00 and gave the stock a "buy" rating in a report on Thursday.
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Sees Large Volume Increase Following Analyst Upgrade
Applied Therapeutics (NASDAQ:APLT) Sees Strong Trading Volume on Analyst Upgrade
Applied Therapeutics, Inc. stock logo
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been assigned a consensus rating of "Buy" from the six research firms that are presently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has assigned a strong
Fed cuts rates by 50 basis points: Yahoo Finance
Applied Therapeutics, Inc. stock logo
Stock Traders Purchase High Volume of Call Options on Applied Therapeutics (NASDAQ:APLT)
Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors bought 10,681 call options on the company. This represents an increase of approximately 2,011% compared to the average daily volume of 506 call options.
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Shares Down 4.1%
Applied Therapeutics (NASDAQ:APLT) Shares Down 4.1%
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Shares Down 6.9%
Applied Therapeutics (NASDAQ:APLT) Trading Down 6.9%
Applied Therapeutics: Pushing Towards FDA Approval
Applied Therapeutics, Inc. stock logo
Applied Therapeutics (NASDAQ:APLT) Stock Price Down 5.3%
Applied Therapeutics (NASDAQ:APLT) Trading Down 5.3%
Applied Therapeutics, Inc. stock logo
Peregrine Capital Management LLC Purchases Shares of 731,048 Applied Therapeutics, Inc. (NASDAQ:APLT)
Peregrine Capital Management LLC purchased a new stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 731,048 shares of the company's stock, valued at ap
Applied Therapeutics, Inc. stock logo
Citigroup Increases Applied Therapeutics (NASDAQ:APLT) Price Target to $8.00
Citigroup boosted their price target on Applied Therapeutics from $7.00 to $8.00 and gave the company a "buy" rating in a report on Tuesday.
Get Applied Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

APLT Media Mentions By Week

APLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APLT
News Sentiment

0.10

0.57

Average
Medical
News Sentiment

APLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APLT Articles
This Week

8

3

APLT Articles
Average Week

Get Applied Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:APLT) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners